Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
04/15/16OraSure Technologies Appoints New Chief Science Officer
Michael Reed, Ph.D. named Senior Vice President of Research and Development and Chief Science Officer BETHLEHEM, Pa., April 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that Michael Reed, Ph.D. has been named as the Company’s Senior Vice President of Research and Development and Chief Science Officer. He will begin working at the Company on April 18, 2016. Dr. Reed brings to OraSure Technologies more than 20 years of experience in life sciences and ... 
Printer Friendly Version
04/13/16OraSure Technologies Earnings Conference Call Invitation
2016 First Quarter Earnings Conference Call Wednesday, May 4, 2016, 5:00 p.m. ET BETHLEHEM, Pa., April 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 first quarter financial results, 2016 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2016.      May 4, 2016 Schedule   4:00 p.m. ET   ... 
Printer Friendly Version
03/23/16OraSure Technologies Appoints Eamonn P. Hobbs to its Board of Directors
BETHLEHEM, Pa., March 23, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), today announced the appointment of Mr. Eamonn P. Hobbs as a member of the Company's Board of Directors.  Mr. Hobbs will serve as a Class I Director with an initial term expiring at the Company’s 2016 Annual Meeting of Stockholders.  He will also serve on the Company’s Audit and Compensation Committees. "We are delighted to welcome Eamonn Hobbs as a new member of our Board of Directors," said Douglas... 
Printer Friendly Version
02/26/16OraSure Technologies to Present at the Raymond James 37th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 26, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak March 7, 2016, at approximately 8:40 AM Eastern Time (5:40 AM Pacific Time).  Interested investors can access the live... 
Printer Friendly Version
02/03/16OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015
BETHLEHEM, Pa., Feb. 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the full-year and fourth quarter ended December 31, 2015. Financial Highlights Consolidated net revenues for the fourth quarter of 2015 were $32.4 million, a 13% increase from the fourth quarter of 2014. Consolidated net revenues for the year ended December 31, 2015 ... 
Printer Friendly Version
01/13/16OraSure Technologies Earnings Conference Call Invitation
2015 Fourth Quarter Earnings Conference Call Wednesday, February 3, 2016, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2015 fourth quarter financial results, 2016 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 3, 2016.   February 3, 2016 Schedule 4:00 p.m. ET 2015 fourth ... 
Printer Friendly Version
12/08/15DNA Genotek Inc. Appoints Microbiome Data Scientist as Advisor
Dan Knights, PhD, Brings Deep Experience in Microbiome Analysis and Biomarker Discovery OTTAWA, ON, December 8, 2015. DNA Genotek, a leading provider of sample collection kits and end-to-end services for human genomics, microbiome and infectious disease, today announced Dan Knights, PhD – an expert in machine learning and microbiome analysis – as a scientific advisor to the company. Dr. Dan Knights is a computational microbiologist and a leading authority in the application of machine learning... 
Printer Friendly Version
11/10/15OraSure Technologies to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
BETHLEHEM, Pa., Nov. 10, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technology & Diagnostic Forum in New York City, New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 19, 2015, at approxima... 
Printer Friendly Version
11/04/15OraSure Announces 2015 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 04, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2015. Financial Highlights Consolidated net revenues for the third quarter of 2015 were $29.9 million, a 7% increase from the comparable quarter of 2014. Consolidated net revenues for the nine months ended September 30, 2... 
Printer Friendly Version
10/14/15OraSure Technologies Earnings Conference Call Invitation
2015 Third Quarter Earnings Conference Call  Wednesday, November 4, 2015, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 14, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2015 third quarter financial results, 2015 fourth quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 4, 2015.  November 4, 2015 Schedule     4:00 p.m. ET ... 
Printer Friendly Version